APCs particularly dendritic cells (DC) sample antigens from tumor cells and present antigens to CD4+ T cells via the MHC class-II pathway or to CD8+ T-cells via cross presentation or cross priming [83, 84]. The gene discussed is HLA-C; the disease is neoplasm.